Login

SANGUI BIOTECH INTERNATIONAL INC 5 SEC Filings

Filed On Filing
12 Aug 2022 Form 5: Striepe Thomas, Director

Holds 1,350,000 shares of Common Stock

12 Aug 2022 Form 5: Schmelz Hubertus, Director

Holds 17,606,481 shares of Common Stock

13 Aug 2021 Form 5: Schmelz Hubertus, Director

Holds 18,806,481 shares of Common Stock

13 Aug 2021 Form 5: Striepe Thomas, Director

Holds 1,350,000 shares of Common Stock

31 Jul 2020 Form 5: Schmelz Hubertus, Director

Holds 18,806,481 shares of Common Stock

31 Jul 2020 Form 5: Striepe Thomas, Director

Holds 1,350,000 shares of Common Stock

27 Aug 2019 Form 5: Schmelz Hubertus, Director

Holds 18,806,481 shares of Common Stock

27 Aug 2019 Form 5: Striepe Thomas, Director

Holds 1,350,000 shares of Common Stock

06 Sep 2018 Form 5: Schmelz Hubertus, Director

Bought 200,000 shares ($6.8K) · Bought 88,780 shares ($2.28K) · Bought 100,000 shares ($3K) · 11 more

29 Aug 2018 Form 5: Striepe Thomas, Director

Holds 1,350,000 shares of Common Stock

12 Oct 2016 Form 5: Striepe Thomas, Director

Holds 1,350,000 shares of Common Stock

12 Oct 2016 Form 5: Schmelz Hubertus, Director

Bought 3,575,000 shares ($56.8K)

09 Sep 2015 Form 5: Schmelz Hubertus, Director

Holds 10,702,601 shares of Common Stock

09 Sep 2015 Form 5: Striepe Thomas, Director

Holds 1,350,000 shares of Common Stock

09 Sep 2015 Form 5: Fleing Joachim, Director

Holds 1,744,193 shares of Common Stock

21 Jul 2014 Form 5: Schmelz Hubertus, Director

Holds 10,702,601 shares of Common Stock

21 Jul 2014 Form 5: Striepe Thomas, Director

Holds 1,350,000 shares of Common Stock

21 Jul 2014 Form 5: Fleing Joachim, Director

Holds 1,744,193 shares of Common Stock

19 Jul 2013 Form 5: Striepe Thomas, Director

Holds 1,350,000 shares of Common Stock

17 Jul 2013 Form 5: Schmelz Hubertus, Director

Holds 10,702,601 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support